Aripiprazole [Regulatives / Guidelines]

posted by shankar – India, 2013-12-13 09:00 (4576 d 07:16 ago) – Posting: # 12052
Views: 5,348

Dear Helmut,

Please let me know why FDA guidance for Aripiprazole bioequivalence study recommending Fasting and fed study for 10 mg and fasting study for 5 mg?

The strength available is 2 mg, 5 mg, 10 mg, 15 mg, 20 mg and 30 mg and the literature indicates Aripiprazole having liner pharmacokinetics.

If the drug has linear kinetics why BE study conducted for 5 mg also?

Regards,

Shankar

Shankaranarayanan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
124 visitors (0 registered, 124 guests [including 18 identified bots]).
Forum time: 17:17 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5